Leukemia & lymphoma/Leukemia and lymphoma

Taylor & Francis

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Leukemia & lymphoma/Leukemia and lymphoma is a journal published by Taylor & Francis in Switzerland. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis
ISSN
1029-2403 · 1026-8022
Country
Switzerland
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1992-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

14228

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

118

i10-index

7000

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
99%
ORCID iDs in current deposits
69%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Leukemia and lymphoma
Source type
journal
NLM unique ID (PubMed)
9007422
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
Show all subjects (50)
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Retinoids in leukemia and cellular processes
  • Retinoids in leukemia and cellular processes
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • T-cell and Retrovirus Studies
  • T-cell and Retrovirus Studies
  • Cutaneous lymphoproliferative disorders research
  • Cutaneous lymphoproliferative disorders research
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: